Market Cap (In NOK)
70.53 Million
Revenue (In NOK)
-
Net Income (In NOK)
-189.23 Million
Avg. Volume
355.36 Thousand
- Currency
- NOK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.57-165.0
- PE
- -0.3534
- EPS
- -5.8
- Beta Value
- 0.986
- ISIN
- NO0010851603
- CUSIP
- -
- CIK
- -
- Shares
- 34406100.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Carlos de Sousa
- Employee Count
- -
- Website
- https://ultimovacs.com
- Ipo Date
- 2019-06-03
- Details
- Ultimovacs ASA, a pharmaceutical company, develops immunotherapies for cancers. Its lead product candidate is UV1, a peptide-based vaccine that induces T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.
More Stocks
-
HRSEFHirose Electric Co.,Ltd.
HRSEF
-
336570WON TECH Co.,Ltd.
336570
-
LOKESHMACHLokesh Machines Limited
LOKESHMACH
-
GOLKONDA
-
BYIT
-
VOD
-
MLBONbonyf N.V.
MLBON
-
0873